IMMUTEP Ltd
IMMP · XNASCIK 1506184fmd_0STJ4Y018SNQK5R4JT9JF9B0NVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2015 to Jun 30, 2026, 11 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 4 | 7 | 7 | 16 | 4 | 7 | 5 | 8 | 10 |
| Research and development | 7 | 8 | 10 | 14 | 16 | 12 | 25 | 29 | 31 | 50 |
| Interest expense | 0 | – | – | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before taxes | (63) | (10) | (13) | (18) | (13) | (30) | (32) | (40) | (43) | (61) |
| Income tax expense | (1) | (1) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (62) | (9) | (13) | (18) | (13) | (30) | (32) | (40) | (43) | (61) |
| Net income | (62) | (9) | (13) | (18) | (13) | (30) | (32) | (40) | (43) | (61) |